Wellstar International, Inc. (OTCBB: WLSI), a developer of thermal imaging, diagnostic software and equipment, announced today that it has made another key appointment to its medical advisory board. Ms. Edna Edwards Atwater, RN, BSN, widely respected as a premier wound care specialist, and current administrator at the Wound Management Institute of Duke University Medical Center, has already been serving as consultant to Wellstar and will now join Dr. Shen, Dr. Makowka and Courtney Lyder, ND to advise the rapidly emerging company on the medical and health care administration aspects of the Company’s business activities.
EDNA EDWARDS ATWATER, RN, BSN
Edna Edwards Atwater has been a registered nurse in the state of North Carolina since 1975. Among her professional appointments, she has served as President of the Dermatology Nurses’ Association, Chairperson of the Surgical Core Curriculum, Dermatology Nurses’ Association, on the Health Policy Committee, National Federation of Specialty Nursing Organization, and Dermatology Nurses’ Association Representative to the National Pressure Ulcer Advisory Panel. Atwater has served as an administrator / director for the Wound Management Institute of Duke University Medical Center, in addition to several other key roles for Duke, since 1998. Wellstar is very pleased that Edna Edwards Atwater has agreed to join the Company’s advisory board, and anticipates that she will play a very big role in the Company’s efforts to roll-out its thermal imaging systems nationwide.
Current shareholders and interested investors seeking additional biographical / background information on Edna Edwards Atwater, or any of the four newly appointed advisors to Wellstar, should visit the Company’s corporate Website at www.wellstar.us. Curriculum vitae for all four can be downloaded in PDF format. In addition, interested investors seeking further information are encouraged to call the Company’s investor relations’ representatives toll-free at (800) 953-3350.
ABOUT WELLSTAR INTERNATIONAL, INC:
Wellstar International, Inc., through its wholly owned operating subsidiary Trillenium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body. More information on the Company and its unique diagnostic software and product line is available on Wellstar’s corporate Website, by visiting: www.wellstar.us.
FORWARD-LOOKING STATEMENTS:
This press release contains statements, which may constitute ‘forward- looking statements’ within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
CONTACT: Equiti-trend Advisors LLC (800) 953-3350 Toll-Free, U.S. & Canada (858) 436-3350 Local or International
SOURCE: Wellstar International, Inc.
Comments